Breaking News, Financial News

Abbott Laboratories

Strong pharma growth driven by Humira

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott Laboratories 2Q10 2Q Revenues: $8.8 billion (+18%) 2Q Earnings: $1.3 billion (flat) YTD Revenues: $16.6 billion (+16%) YTD Earnings: $2.3 billion (-16%) Comments: Pharma sales were $4.9 billion (+25%) in 2Q10, boosted by a favorable exchange rate and revenues from Solvay Pharmaceuticals. YTD pharma revenues were up 19% to $9.0 billion. Humira continued its meteoric rise, posting 22% growth in 2Q10 and 28% for YTD, to $1.6 billion and $3.0 billion, respectively. Kaletra reve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters